A paper entitled "Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping" was published in the highly ranked journal Nature Immunology on July 2. This work will be an important resource when designing new NK cell therapies.
The authors have been analyzing transcriptional data from 427 patients and 39 datasets, including 7 solid tumor types (lung, brain, skin, pancreas, prostate, breast, sarcoma). They could identify 6 different functional states of tumor-infiltrating NK cells, and the state of the NK cells correlate with survival for cancer patients. 

Tore Skotland and Kirsten Sandvig, Department of Molecular Cell Biology, Institute for Cancer Research, have together with four international experts on mass spectroscopy (MS) analyses of lipids, published a short comment (2 pages with a supplementary of 2 pages) in Nature Reviews Molecular Cell Biology.

The article is entitled “Pitfalls in lipid mass spectroscopy of mammalian samples – a brief guide for biologists”. 

In 2024, the Institute for Cancer Research at Oslo University Hospital turns 70 years old. The institute has more than 380 employees spread over seven sections and constitutes Norway's largest cancer research environment.
The institute marks 70 years with an anniversary symposium at The Hub in Oslo 9-10 September, with support from Hydro's Fund for Cancer Research.
A special highlight will be the opening lecture by Douglas Hanahan, entitled "Hallmarks of Cancer in 2024".
The deadline for early registration is 8 July, and the late registration deadline is 5 August.

Three Oslo University Hospital scientists received prestigous awards for their outstanding research on Friday June 14th.
The major prize - the "Excellent Researcher Award" - went to Kjetil Taskén.
Chloé Beate Steen and Andreas Kleppe both received the "Early Career Award".
The prize money - 400.000 and 200.000 NOK respectively - is earmarked for research activities.

The awards are distributed anually in order to honour excellent scientific work. The awarding process is organized by the hospital's research committee, while an external Scientific Advisory Board has evaluated the candidates. 

Helse Sør-Øst RHF announces NOK 130 million for health research in the region. In addition, up to NOK 10 million will be allocated targeted funding within prioritised thematic areas, and up to NOK 5 million will be allocated strategic research funding to non-university hospitals.

The application deadline is Wednesday 4th September 2024 at 16:00

For 2025, research funding is available within the following application categories: 

• Doctoral grants 
• Postdoctoral grants 
• Open project support 

In order to stimulate excellent research and draw attention to the hospital's research activity, Oslo University Hospital rewards outstanding publications every half-year.

Six research groups were awarded for their excellent papers published the second half-year of 2023 during a ceremony on June 7th. Each group received NOK 50.000 earmarked for further research, and the prize winners gave short presentations of their main findings.